Rebecca Derwin

Rebecca Derwin

Company: Sobi

Job title: Global Commercial Lead – Gamifant

Seminars:

Rare Disease Commercialization: Tailoring Your Launch Excellence Strategies in Uncharted Waters 10:30 am

Leveraging ideas from blueprint strategies while tailoring them to the unique needs of each rare disease Understanding how unique aspects of a treatment, patient experience and health systems may impact your commercialization plans and how we can adapt a basic strategy to each rare disease Key considerations in preparing for a launch in an uncharted…Read more

day: Conference Day One

Building A Go-To-Market Strategy with Value for All Players & Stakeholders in Rare Disease 8:00 am - 10:00 am

Unlike traditional pharmaceuticals, rare disease commercialization requires a deeply specified roadmap, where patient engagement, access strategies, and regulatory navigation must be customized to the nuances of each disorder, making templated approaches ineffective. How to plan and create road maps to a successful commercial strategy How best to assess treatment guidelines, current treatments & regulations to…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.